# Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC

Source: https://onco.cc/trials/nct06672133/  
OnCo record `nct06672133` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of adebrelimab in lung cancer, run by Jinming Yu, not yet recruiting.

## Summary

Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC is a phase 3, randomised interventional study registered as NCT06672133 by Jinming Yu, with a registry enrolment figure of 524 participants, started 2024-12 and due to reach its primary completion in 2029-06. Interventions recorded: Adebrelimab; Radiation Therapy. Conditions listed: Extensive Stage Lung Small Cell Carcinoma. Primary outcome: PFS; OS. Lung eligibility wording from the registry: "Histologically or cytologically confirmed extensive stage small cell lung cancer (according to the Veterans Lung Administration Lung Study Group, VALG stage);". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-25
- Also known as: RALLY
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06672133
- Phase: 3
- Setting: Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC: a Randomized Controlled Phase III Clinical Study
- Sponsor: Jinming Yu
- Enrolled: 524

## Sources

- ClinicalTrials.gov NCT06672133: https://clinicaltrials.gov/study/NCT06672133

## Connected records

- cancers: [Extensive-stage small-cell lung cancer](https://onco.cc/cancers/extensive-stage-sclc/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- drugs: [Adebrelimab](https://onco.cc/drugs/adebrelimab/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06672133.json